This paper is published in Volume-5, Issue-4, 2019
Area
Medicine
Author
Arun S. Karthikeyan, Jacob John, Gagandeep Kang
Org/Univ
Christian Medical College, Vellore, Tamil Nadu, India
Keywords
Immunization coverage, Vaccine timeliness, Universal Immunization Program
Citations
IEEE
Arun S. Karthikeyan, Jacob John, Gagandeep Kang. Routine and research cohort coverage of vaccines in Tamil Nadu: Implications for the Universal Immunization Program, International Journal of Advance Research, Ideas and Innovations in Technology, www.IJARIIT.com.
APA
Arun S. Karthikeyan, Jacob John, Gagandeep Kang (2019). Routine and research cohort coverage of vaccines in Tamil Nadu: Implications for the Universal Immunization Program. International Journal of Advance Research, Ideas and Innovations in Technology, 5(4) www.IJARIIT.com.
MLA
Arun S. Karthikeyan, Jacob John, Gagandeep Kang. "Routine and research cohort coverage of vaccines in Tamil Nadu: Implications for the Universal Immunization Program." International Journal of Advance Research, Ideas and Innovations in Technology 5.4 (2019). www.IJARIIT.com.
Arun S. Karthikeyan, Jacob John, Gagandeep Kang. Routine and research cohort coverage of vaccines in Tamil Nadu: Implications for the Universal Immunization Program, International Journal of Advance Research, Ideas and Innovations in Technology, www.IJARIIT.com.
APA
Arun S. Karthikeyan, Jacob John, Gagandeep Kang (2019). Routine and research cohort coverage of vaccines in Tamil Nadu: Implications for the Universal Immunization Program. International Journal of Advance Research, Ideas and Innovations in Technology, 5(4) www.IJARIIT.com.
MLA
Arun S. Karthikeyan, Jacob John, Gagandeep Kang. "Routine and research cohort coverage of vaccines in Tamil Nadu: Implications for the Universal Immunization Program." International Journal of Advance Research, Ideas and Innovations in Technology 5.4 (2019). www.IJARIIT.com.
Abstract
Immunization coverage in Indian states varies from 24.8 % to 89.7%. Comparison between the routine vaccine coverage with two research cohorts in Tamil Nadu showed the routine immunization system performed well with >80% coverage for EPI vaccines and reasonable timeliness. Given Tamil Nadu’s performance, this and similar states should not be denied access to new antigens, pending improvement in coverage in other parts of India.
